Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic review and meta-analysis

Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic review and meta-analysis

This study comprehensively evaluated and compared three human rabies vaccines. Seven electronic databases were systematically searched. The Cochrane Handbook v5.1.0 was used to assess the risk of bias. A random-effects model was used to combine individual rates, and network meta-analysis was used fo...

Full description

Bibliographic Details
Main Authors:	Shi-Yuan Wang, Jin-Fang Sun, Pei Liu, Li Luo, Jing-Xin Li, Feng-Cai Zhu, Xu-Xiang Shen, Fan-Yue Meng
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-01-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	rabies vaccines post-exposure prophylaxis immunogenicity adverse reaction meta-analysis
Online Access:	http://dx.doi.org/10.1080/21645515.2022.2027714

Similar Items

Purified Vero Cell Rabies Vaccine (PVRV, Verorab<sup>®</sup>): A Systematic Review of Intradermal Use Between 1985 and 2019
by: Thomas Moulenat, et al.
Published: (2020-03-01)

Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis
by: Scott Preiss, et al.
Published: (2018-06-01)

Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd
by: Prasad S. Kulkarni, et al.
Published: (2017-04-01)

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
by: D.J. Briggs, et al.

Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults
by: Sylvie Pichon, et al.
Published: (2023-12-01)

Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial
by: Xingyu Zhou, et al.
Published: (2019-04-01)

Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
by: Jing Wang, et al.
Published: (2017-01-01)

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
by: Nianmin Shi, et al.
Published: (2017-06-01)

Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study
by: Gadey Sampath, et al.
Published: (2017-07-01)

Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children
by: Piyada Angsuwatcharakon, et al.
Published: (2018-02-01)

Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial
by: Lei Zhang, et al.
Published: (2021-08-01)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
by: Xiaoyuan Huang, et al.
Published: (2023-01-01)

Design of methods assessing efficacy of antirabic vaccine prophylaxis
by: V V Nedosekov, et al.
Published: (2004-04-01)

Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial
by: Heng Shen, et al.
Published: (2021-02-01)

Antibody and cytokine serum levels in patients subjected to anti-rabies prophylaxis with serum-vaccination
by: J. A. Ayres, et al.
Published: (2006-01-01)

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
by: Pornthep Chanthavanich, et al.
Published: (2018-04-01)

Purified Vero cell rabies vaccine and human diploid cell strain vaccine: comparison of neutralizing antibody responses to post-exposure regimens.
by: Suntharasamai, P, et al.
Published: (1986)

The Route of Administration of Rabies Vaccines: Comparing the Data
by: Deborah J. Briggs, et al.
Published: (2021-06-01)

Long-term immunity and the effect of one or two booster doses with a lyophilized human rabies vaccine (human diploid cells) at 10 years post primary vaccination in China
by: Jialei Hu, et al.
Published: (2021-09-01)

Two decades of pharmacovigilance and clinical experience with highly purified rabies immunoglobulin F(ab')2 fragments
by: Elisa Reveneau, et al.
Published: (2017-03-01)

Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis.
by: Suntharasamai, P, et al.
Published: (1987)

New purified Vero-cell vaccine prevents rabies in patients bitten by rabid animals.
by: Suntharasamai, P, et al.
Published: (1986)

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
by: Weerawan Hattasingh, et al.
Published: (2022-01-01)

Satisfactory immune response following anaphylaxis to PCECV facilitated by the use of steroids and antihistamines
by: Abishek Tumma, et al.
Published: (2020-06-01)

Human rabies post-exposure prophylaxis: a review of the treatment of accidents involving domestic cats
by: Isabela de Lourdes Araújo, et al.
Published: (2022-08-01)

Molecular Genetic Testing of Stability and Identification of Vnukovo-32 Strain Used for Production of the Cultural Concentrated Purified Inactivated Dry Rabies Vaccine
by: G. M. Ignatyev, et al.
Published: (2020-06-01)

Post-exposure rabies prophylaxis in humans exposed to animals in Lublin province (Eastern Poland) in 2012–2015 – A retrospective study
by: Joanna Krzowska-Firych, et al.
Published: (2017-06-01)

Shall We Leave Semple-Type Rabies Vaccines, Why ?
by: Paşa GÖKTAŞ
Published: (1996-06-01)

Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study
by: Ravish H S, et al.
Published: (2021-11-01)

Post-Exposure Prophylactic Vaccination against Rabies: A Systematic Review
by: Norfazilah Ahmad, et al.
Published: (2022-05-01)

A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures
by: Xiaohong Wu, et al.
Published: (2023-08-01)

Investigating Possible Etiologies of Post-Exposure Prophylaxis Failure and Deaths From Rabies Infection: Case Reports
by: Azadeh Rasooli, et al.
Published: (2020-09-01)

Background paper for developing a policy for the use of rabies biologicals and vaccination of humans in India
by: Mysore Kalappa Sudarshan, et al.
Published: (2019-01-01)

New Rabies Vaccines for Use in Humans
by: Hildegund C. J. Ertl
Published: (2019-06-01)

Safety and immunogenicity of rabies vaccine as 4 - dose Essen Intramuscular regimen for post exposure prophylaxis: A non - randomized, comparative controlled study
by: Ravish S. Haradanahalli, et al.
Published: (2021-08-01)

Cell Structures in Heterologous Anti-Rabies Immunoglobulin Production
by: S. V. Generalov, et al.
Published: (2011-08-01)

Pattern of animal bites and factors associated with delay in post-exposure prophylaxis in bitten people
by: Khaled Samiee-Roudi
Published: (2018-09-01)

Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine
by: Anurag Agarwal, et al.
Published: (2022-11-01)

Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial
by: Mark A. Matson, et al.
Published: (2020-02-01)

Potency, immunogenicity, and efficacy of rabies vaccine: In vitro and in vivo approach
by: Fahima Akter, et al.
Published: (2024-02-01)